Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Charles Baker currently holds 7,843 shares of Vallon Pharmaceuticals, Inc. (VLON), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Charles Baker has been a net buyer of VLON stock. They have purchased $8.0K and sold $0 worth of shares.
David Charles Baker's most recent insider trade was on Feb 12, 2021, when they sold 7,843 shares at $6.40 per share.
David Charles Baker serves as Executive at Vallon Pharmaceuticals, Inc. (VLON). They have executed 2 insider transactions totaling $8.0K over their tenure at the company.
David Charles Baker holds the position of Executive at Vallon Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
David Charles Baker has shown a buying trading pattern, with $8.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by David Charles Baker was on Feb 12, 2021, when they sold $50.2K worth of VLON shares. This transaction involved 7,843 shares at $6.40 per share.
David Charles Baker currently owns 7,843 shares of Vallon Pharmaceuticals, Inc. (VLON), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Charles Baker's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Charles Baker has 2 Form 4 filings on record as an insider at Vallon Pharmaceuticals, Inc..
Set alerts for David Charles Baker and 40,000+ other insiders.